Altered circadian rhythms and sleep in aging and sex as factors in nocturia by Park, Hongchai
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2013
Altered circadian rhythms and
sleep in aging and sex as factors in
nocturia
https://hdl.handle.net/2144/12181
Boston University
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
Thesis 
 
 
 
 
ALTERED CIRCADIAN RHYTHMS AND SLEEP IN AGING AND SEX AS 
FACTORS IN NOCTURIA 
 
 
by 
 
 
HONGCHAI PARK 
 
B.A., University of Illinois, 2011 
 
 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Arts 
 
2013
   
Approved by 
 
 
 
 
 
 
 
 
 
First Reader   
  
 R.J. Rushmore III, Ph.D.  
 Assistant Professor of Anatomy & Neurobiology 
 
 
 
 
 
 
 
 
 
Second Reader   
  
 Jeanne F. Duffy, Ph.D. 
 Associate Professor of Medicine, 
 Harvard Medical School 
 iii 
  
ACKNOWLEDGEMENTS  
 
I would like to express my deep gratitude to Dr. Jeanne F. Duffy, my research supervisor 
and mentor, for her patient guidance, encouragement and useful critiques of this research 
work. She has kept me on track and always held me to high standards, helping me to truly 
appreciate clinical research. 
I would also like to thank Dr. R.J. Rushmore for his understanding, helpful advice, and 
earnest interest in my research. His humor and amiability comforted me when I was 
overwhelmed by this endeavor. 
My grateful thanks are also extended to Dr. Kevin Loughlin for agreeing to collaborate 
on the questionnaire studies and Mike Meyers for helping collect the questionnaire data. 
Finally, I wish to thank Dr. Chang G. Park for his help in doing the statistical analysis.  
 iv 
ALTERED CIRCADIAN RHYTHMS AND SLEEP IN AGING AND SEX AS 
FACTORS IN NOCTURIA 
 
HONGCHAI PARK 
 
 
Boston University School of Medicine, 2013 
 
Major Professor: R.J. Rushmore III, Ph.D., Assistant Professor of Anatomy & 
Neurobiology 
ABSTRACT 
Background: Nocturia is one of the most common causes of sleep disruption and of 
reduced quality of life. This nocturnal tendency to void increases with age, and is 
reported to affect men more than women. The underlying causes of these age- and sex-
related differences have been inconsistently explained in literature. There are age-related 
changes in sleep architecture and in the day-night rhythm of urine output, but how each 
of these changes influence nocturnal voiding is unclear. Furthermore, sex-related 
differences sleep architecture are not well linked to nocturia. 
Diminished urine output is achieved through urine concentration either via water 
reabsorption or sodium retention. There is a day-night variation in urine output in 
humans, with nighttime output in healthy young adults representing about 25% of total 
24-hour production. A variety of hormones play a role in fluid and sodium balance, 
including vasopressin, atrial natriuretic peptide, and the renin-angiotensin-aldosterone 
system. Several of these hormones have been reported to show day-night variations, but 
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whether these represent circadian rhythms or effects of day-night changes in behavior is 
not clear. Without understanding how diuretic and anti-diuretic hormones vary across day 
and night, their role in nocturia remains unclear. Furthermore, if changes in the amplitude 
of the circadian rhythm of such hormones occur with age, it represents a potential novel 
mechanism contributing to nocturia, and a potential therapeutic target. 
 
Methods: We conducted two studies to investigate the connection between nocturia and 
age- and sex-related changes in sleep and circadian rhythms. In the first study, four 
questionnaires were given to 291 older adults, 204 males and 87 females. The 
questionnaires asked about sleep quality, daytime sleepiness, urological complaints, and 
general napping and medications.  Questionnaire responses were compared between the 
men and women to determine if there were sex-related differences in sleep and urological 
complaints. To investigate associations between urological complaints and sleep 
complaints, the responses on the questionnaires were also compared within each group. 
The second study consisted of ten healthy young adults and nine healthy older 
adults who each took part in a multi-day inpatient circadian rhythm study. That study 
included a constant routine (CR) circadian phase and amplitude assessment during which 
activity, posture, sleep-wake state, room environment, and food and fluid intake were 
controlled throughout day and night. Blood samples for hormone analysis were collected 
every 4 hours throughout the CR and assayed after the study was complete for 
aldosterone, atrial natriuretic peptide, and vasopressin using a radioimmunometric assay. 
The data from the participants in each age group were averaged and cosinor analysis was 
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used to determine whether there was significant circadian rhythmicity in the hormone 
data, and if so whether the hormone timing and amplitude differed between the two age 
groups. 
 
Results: In the questionnaire study, there was a positive correlation between sleep 
complaints and urological complaints in women. In men, there was a positive correlation 
between sleep complaints and daytime sleepiness, daytime sleepiness and urological 
complaints, and sleep complaints and urological complaints. 
In the hormone study, there was a significant circadian variation in aldosterone 
for young subjects (but not older subjects), and the waveform was well-described by a 
cosine model. None of the other hormones exhibited a significant circadian variation in 
either age group. 
 
Conclusion: In the questionnaire study, we found that poorer sleep quality was associated 
with more urological complaints in both women and men. In men, daytime sleepiness 
was also correlated with urological complaints, and decreased quality of sleep was 
correlated with increased daytime sleepiness. 
In the hormone study, we found evidence for a sleep-independent increase in 
aldosterone levels at night, suggestive of an underlying rhythm in aldosterone secretion. 
This circadian rhythm in aldosterone secretion may contribute to the circadian rhythm in 
urine production, and further studies are required to determine whether a change in the 
amplitude of this rhythm with aging is associated with nocturia. 
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INTRODUCTION 
Nocturia 
The International Continence Society defines nocturia as waking one or more 
times at night to void, while more recently the American Urological Association has 
defined it as the need to urinate at least twice during the night (Abrams et al., 2002; 
Brawer et al., 2007). Traditionally, voiding during the night was attributed to benign 
prostate hypertrophy (BPH), a problem only found in males (Weiss, Blaivas, Stember, & 
Brooks, 1998). Yet surgical therapy of these obstructions have been found to be generally 
ineffective (Alternate methods in the treatment of benign prostatic hyperlasia, 1993). The 
traditional beliefs of nocturia have become obsolete as more studies are being done on 
this condition. Defining the need to void at night has been useful for determining its 
impact as a symptom of various disorders and diseases (Levkowicz, Whitmore, & Muller, 
2011). It is now well-known that nocturia is a multifactorial condition, from nocturnal 
polyuria and detrusor over-activity to uncompensated heart disease and estrogen 
deficiency (Weiss & Blaivas, 2000). 
Weiss et al. have proposed a classification of a system to better identify the 
etiology of nocturia and the appropriate treatment (Weiss et al., 1998). As the definitions 
have varied, it has been difficult to measure the prevalence of nocturia, but it is well-
established that complaints of voiding at night are not limited to men (Wein, Lose, & 
Fonda, 2002). Weiss et al. has described three general pathophysiologies for nocturia: 1) 
decreased nocturnal bladder capacity; 2) nocturnal polyuria; or 3) a combination of the 
two. Daytime polyuria, or having a 24-hour urine output greater than 2500 mL may be 
 2 
responsible for an increased urine production, but is classified separately (Weiss et al., 
1998). Nocturnal polyuria is an increased urinary output during the night of 35% or more 
of the normal 24-hour urine production (Asplund, 1995; Weiss, Blaivas, Stember, & 
Chaikin, 1999). Some causes of nocturnal polyuria include congestive heart failure, sleep 
apnea, or excess fluid intake before bedtime (“Nocturia,” 2009). Diminished nocturnal 
bladder capacity occurs when the volume voided at night is less than the functional 
bladder capacity (the maximum volume of void) (Abrams, Blaivas, Stanton, & Andersen, 
1988). Some causes of low nocturnal bladder capacity include bladder obstruction, 
bladder inflammation, or benign prostatic hyperplasia (“Nocturia,” 2009). The 
multifactorial etiology of nocturia is becoming more recognized. The standardization 
committee of International Continence Society has further defined various terms of 
nocturia so that different medical specialties could more clearly communicate about this 
common symptom, and have helped identify ways to treat the different causes of nocturia 
(Abrams et al., 2002). 
To fully determine the etiology of nocturia, an evaluation beyond the bladder 
should be done. A general physical examination may include assessing genitourinary 
health, checking for bladder distension, and evaluating for autonomic neuropathy (T. 
Johnson, 2013). Laboratory tests may include fluid or electrolyte assessment, urinalysis, 
bladder ultrasound, tissue cultures, and polysomnograms. The standardization 
subcommittee of the International Continence Society recommends keeping a frequency-
volume chart to help clinicians distinguish between the three etiologies of nocturia 
(Abrams et al., 2002). This chart is a diary for patients to record the number, volume, and 
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timing of voids over 24 hours in order to calculate various indices in guiding the 
differential diagnosis of nocturia (Weiss et al., 1998, 1999). It is important to determine 
the underlying cause of nocturia to most effectively treat the condition with the 
appropriate intervention and medication. 
 
Characteristics of Sleep 
Sleep is well recognized but not thoroughly understood. This mysterious 
unconscious state is a time when the body can recover and consolidate memory, and has 
many detrimental effects on health when sleep needs aren‟t met, such as lowering life 
expectancy and decreasing cardiovascular health (Sejnowski & Destexhe, 2000). The 
ubiquity of sleep has made sleep and wakefulness a well-documented behavior found to 
be conserved throughout evolution (Campbell & Tobler, 1984). Based on scientific 
observations, sleep has been characterized by: (1) a period of reduced activity, (2) 
association with a typical posture, (3) decreased response to external stimuli, and (4) a 
state relatively easy to reverse (“The Characteristics of Sleep,” 2007).  
Characteristics of wakefulness and sleep states were established through 
monitoring the electrical activity of neurons with an electroencephalogram (EEG) 
(William Dement & Kleitman, 1957; Loomis, Harvey, & Hobart, 1935). The 
measurements identified differences in brainwave activity between sleep and wakefulness 
and different neuronal firing patterns across a sleep episode. 
In the 1950s and 60s, Kleitman and Aserinsky discovered regular alterations of 
rapid eye movement (REM) and non-REM phases during sleep (Aserinsky & Kleitman, 
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1953). Vivid dreaming was correlated with REM sleep, demonstrating the active aspect 
of sleep. They also elucidated that REM sleep is characterized by a profound loss of 
skeletal muscle tone. The EEG pattern of REM sleep shows faster activity with 
distinctive saw-tooth waves (W Dement & Wolpert, 1958). 
 A typical 8-hour nighttime sleep episode in humans is made up of 4-5 sleep cycles 
(Münch, Cain, & Duffy, 2007). One sleep cycle lasts for about 90-100 minutes, and 
consists of the two distinct stages of REM and non-REM (NREM) sleep. There is a 
longer REM and NREM Stage 2 for the later part of the sleep. The sleep structure can be 
seen in Figure 1. Brain waves decrease in frequency and increase in amplitude on the 
recordings of EEG as wakefulness transitions to sleep (Figure 2). This increase in 
amplitude is a reflection of the rising synchronization of cortical neurons. These EEG 
recordings are used to divide the NREM part of sleep into 3 or 4 stages (Carskadon & 
Dement, 2011). Stage 1 is the transitional stage between the wake and sleep states and 
thus has some alpha waves and low-voltage waves. Alpha waves are characteristic of 
relaxed wakefulness with a range of 8-12 Hz. Stage 2 gets longer after each cycle and has 
low-voltage waves. Sleep spindles and K-complexes are mixed-frequencies that are 
characteristic of Stage 2. Stages 3 and 4 are known as “slow-wave sleep” (SWS), or deep 
sleep, which is found mostly during the one or two sleep cycles. SWS is defined by 
containing more than 20% delta waves (Münch et al., 2007). Delta waves have relatively 
large amplitudes and low frequency (1-3 Hz) and are a result of the synchronization of 
rhythmic thalamocortical activity (Steriade, McCormick, & Sejnowski, 1993).  
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Figure 1 – Representation of the Human Sleep Architecture. REM sleep becomes 
progressively longer across the night and NREM contains less slow-wave sleep (Stage 
3/4) across the night. Figure from (Carskadon & Dement, 2011). 
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Figure 2 – EEG Wave Recordings During Different Brain States. A – Alpha waves 
during quiet wakefulness. B – Stage 1 Sleep. C, D – Stage 2 Sleep. E – Slow-wave sleep 
during Stages 3 and 4. F – REM sleep. Figure adapted from (Münch et al., 2007). 
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Sleep Regulation 
Sleep is the result of two interacting regulatory mechanisms, homeostatic drive 
and circadian rhythmicity. Sleep homeostasis is essentially a sleep drive that increases 
during wakefulness and dissipates during sleep (Borbély & Achermann, 1999). One 
hypothesis suggests that the build-up of adenosine in the brain, a by-product of energy 
consumption, promotes sleep drive (Blanco-Centurion et al., 2006). Any change in the 
accumulation of sleep will change the sleep pressure accordingly. The physiological drive 
for sleep pressure is found to be measured by sleep EEG slow waves (D. J. Dijk, Brunner, 
Beersma, & Borbély, 1990). 
The circadian process is a 24 hour rhythm of sleep propensity through 
physiological activity (Münch et al., 2007). This includes many neuronal and hormonal 
influence on the biological clock where the drive to sleep is stronger at some points and 
weaker at others within the 24-hour day. A healthy individual on a normal day shift work 
schedule would not have problems going to sleep at night because the sleep pressure 
building up during the day is in phase with sleep cycle of the internal circadian rhythm 
which promotes sleep at night. The strongest sleep drives in the adult are typically 
between 2:00 to 4:00 am and 1:00 to 3:00 pm, but can vary widely (“Sleep Topics,” 
2011). Naturally, there will be problems with sleep if the homeostatic sleep drive is 
strongest during the wake cycle of circadian rhythm. For example, a night shift worker 
staying up all night will be working as the internal circadian clock is promoting sleep, 
making it difficult to remain awake. Although the homeostatic drive to sleep continues to 
 8 
build up, the night shift worker may then have trouble going to sleep during the daytime 
because the internal circadian clock is in its wake cycle. 
 
Human Circadian Rhythmicity 
Circadian rhythm is roughly a 24 hour cycle that helps us behave accordingly 
with the day and night cycle. It is ubiquitous in nature – from unicellular organisms to 
mammals (Czeisler et al., 1999). These daily oscillations are generated endogenously and 
are not solely the result of periodic changes in behavior (for example, sleep-wake) or the 
environment (for example, light-darkness). Therefore, a daily rhythm is not a true 
circadian rhythm unless the rhythm is demonstrated to persist in the absence of periodic 
changes in behavior and environmental cues. Therefore, when determining whether a 
rhythm is circadian, periodic zeitgebers (German for “time giver”) such as light-darkness, 
feeding-fasting, activity-rest, must be taken into account and controlled (Lack & Wright, 
2007). In humans, these can be controlled in experiments with Constant Routines, where 
posture, lighting, and food/fluid intake are controlled for at least 24 hours to minimize 
their effects on circadian rhythms (Jeanne F Duffy & Dijk, 2002). 
The suprachiasmatic nucleus (SCN) in humans is a cluster of neurons on the left 
and right side of the third ventricle that hosts the self-sustaining, central pacemaker of the 
biological clock (Suprachiasmatic nucleus, 1991). The main external synchronizer of the 
SCN is light. There are light-sensitive neurons in the retina that relay information of the 
external light/dark cycle from the environment to the SCN through the 
retinohypothalamic tract (RHT) (Takahashi, DeCoursey, Bauman, & Menaker, 1984). 
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Several studies found that blind subjects have free-running rhythms due to the absence of 
light entrainment (Sack, Brandes, Kendall, & Lewy, 2000; Sack, Lewy, Blood, Keith, & 
Nakagawa, 1992). Lockley et al. found that individuals with a particular blindness can 
entrain to day-night cycles, suggesting that there are specific light receptors (Lockley et 
al., 1997). In fact, the SCN can get light signals from the photoreceptors or melanopsin 
containing ganglion cells (Khamsi, 2005). When both of these are affected, the SCN 
cannot get light signals. While light is the dominant synchronizer of circadian rhythm, 
there are several potential non-photic zeitgebers in humans that may act under very 
specialized conditions, and they include exercise, timing of meals, and social cues 
(Mistlberger & Skene, 2005). 
The information received at the SCN is sent to the pineal gland, where melatonin 
is synthesized and secreted (Arendt, 1995). Melatonin conveys the light/dark cycle 
throughout the body (Zhdanova & Tucci, 2003). It is described as the „hand‟ of the clock, 
because the melatonin rhythm can indicate the phase of the SCN. Many other 
physiological processes receive timing information from the SCN. 
 
Circadian Rhythm and Sleep 
The circadian rhythm of sleep propensity plays a significant role in sleep 
architecture and timing in humans. The propensity to fall asleep appears to be determined 
by the circadian system with most rapid increase of sleep propensity after melatonin 
secretion begins and when core temp is falling (D.-J. Dijk & Lockley, 2002; Liu et al., 
2000). The duration, timing, and subjective measures of sleep episodes all vary with 
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circadian phase. The amount of REM sleep varies significantly with the circadian rhythm 
measured by the 24 hour body temperature (Czeisler, Zimmerman, Ronda, Moore-Ede, & 
Weitzman, 1980). An analysis of 359 sleep-wake cycles have shown that the phase of 
circadian rhythm determines the duration of prior wake and sleep length (Strogatz, 
Kronauer, & Czeisler, 1986). In other words, the circadian processes influence the sleep 
length and wake time. There is also an assessment of somnolence by measuring sleep 
latency and presence of REM sleep throughout the day (Carskadon et al., 1986). Several 
measures of sleep quality decline when sleep and circadian phase are not synchronized in 
healthy adults (Campbell & Dawson, 1992). Synchronizing the timing of sleep with the 
circadian phase is important for both healthy and unhealthy subjects (Campbell, Dawson, 
& Anderson, 1993; Ozaki, Uchiyama, Shirakawa, & Okawa, 1996). Without the proper 
synchronization, the body is stressed by unsynchronized sleep pressures. Czeisler and 
Dijk have confirmed that the timing of endogenous circadian phase affects REM sleep, 
and revealed that the pacemaker consolidates sleep most effectively when in phase with 
the sleep episode (D. J. Dijk & Czeisler, 1994, 1995). The appropriate synchronization of 
the circadian pacemaker and the sleep-wake cycles is also critical for better alertness, 
performance, mood, and memory (Boivin et al., 1997; D. J. Dijk, Duffy, & Czeisler, 
1992; M. P. Johnson et al., 1992). 
 
Age-related Changes in Sleep Regulation 
Age-related reduction in uninterrupted sleep is due to an increase in awakenings, 
an increased susceptibility to circadian phase misalignment, and the reduction of sleep 
 11 
duration at all circadian phases (D. J. Dijk, Duffy, & Czeisler, 2001; D. J. Dijk, Duffy, 
Riel, Shanahan, & Czeisler, 1999; D. J. Dijk & Duffy, 1999; J F Duffy, Dijk, Klerman, & 
Czeisler, 1998). The circadian rhythm for older people allows for a smaller opportunity to 
consolidate their sleep. Dijk and Czeisler have revealed a relationship between circadian 
phase and the ability to maintain a high sleep efficiency in both young and older subjects 
(D. J. Dijk & Czeisler, 1994). Older subjects report more difficulty sleeping when sleep-
wake episodes are improperly aligned with the endogenous rhythm (D. J. Dijk et al., 
1999; D. J. Dijk & Duffy, 1999; M L Moline et al., 1992). Young adults are more likely 
to have uninterrupted sleep episodes of 7 to 9 hours than older adults (D. J. Dijk & 
Czeisler, 1995; D. J. Dijk et al., 2001, 1999; J F Duffy et al., 1998).  
Age-related changes in sleep regulation are also present in the homeostatic 
process. Homeostatic sleep pressure can be measured by the EEG power density 
described as slow-wave activity (SWA), primarily measured in NREM sleep (Borbély, 
Baumann, Brandeis, Strauch, & Lehmann, 1981; Brunner, Dijk, Tobler, & Borbély, 
1990). In general, slow-wave sleep is maximal in adolescents and continuously declines 
with age (Carskadon & Dement, 2011). The level of SWA increases with the time awake 
(Brunner et al., 1990; Dijk & Czeisler, 1993; D. J. Dijk, Brunner, Beersma, et al., 1990; 
D. J. Dijk, Brunner, & Borbély, 1990). A study using sleep deprivation reported that 
older people had a homeostatic drive for sleep that could not adequately maintain high 
sleep efficiency towards the end of the sleep episode (D. Dijk, Kelly, Riel, Duffy, & 
Czeisler, 1999). The difference of sleep homeostasis between young and older people 
was further elucidated in a study by Klerman and Dijk (Klerman & Dijk, 2004). In this 
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study, subjects were given 16 hour sleep opportunity per day for 3 days in the laboratory 
after 3 weeks of maintaining their habitual sleep behavior at home. The older group slept 
less during their sleep opportunity. These age-related changes in the homeostatic sleep 
process may contribute to the greater incidence of sleep disturbances.  
Elderly people have weaker regulation of sleep and wakefulness (Cajochen, 
Münch, Knoblauch, Blatter, & Wirz-Justice, 2006). Younger adults spend about half as 
much time during the night in unwanted wakefulness than older adults (D L Bliwise, 
1993). Many studies found that older people complained of involuntarily waking up early 
in the morning (D J Foley et al., 1995; Mant & Eyland, 1988; McGhie & Russell, 1962). 
Dijk et al. reported that the higher likelihood of awakening in the elderly is due to the 
age-related reduction in stages 3 and 4 of NREM sleep (D. J. Dijk et al., 2001). The deep 
sleep of stages 3 and 4 accounts for the difficulty to awaken an individual during these 
stages. The lightening of sleep homeostatic processes with age may be the cause of 
higher sensitivity to disturbances, such as sound or light, while asleep (Zepelin, 
McDonald, & Zammit, 1984). An internal source of awakening may be to empty the 
bladder at night. Voiding at night is reported to be a major cause of sleep disturbance 
affecting around half of the adults in a study across five countries (Irwin et al., 2006). 
These age-related changes in sleep homeostasis may contribute to the higher incidence of 
nocturnal voiding observed with aging (Donald L Bliwise et al., 2009).  The bladder wall 
stretch receptors may more likely awaken older people because less of their sleep is spent 
in the deep slow-wave sleep. Any other internal or external stimulus may awaken older 
people due to the age-related changes in sleep depth and continuity. This greater tendency 
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to be awakened by stimuli from lighter sleep may lead older individuals to be conscious 
of a filled bladder and empty it. It is difficult to ascertain whether people awaken to void 
or realize they have to void after awakening. Older adults have weaker sleep regulation, 
although the underlying cause for age-related differences is not always clear.  
 
Sex Differences in Sleep Regulation 
Delta waves are found primarily during Stages 3 and 4 of NREM, which is also 
known as slow-wave sleep. In one study, women did not show the same significant 
decline in the amount of time spent in stages 3 and 4 of NREM as in men (Sheldon, 
Ferber, & Kryger, 2005). A cross-sectional analysis on over 2,600 participants measured 
the quality of sleep based on sex, ethnicity, and age (Redline et al., 2004). Sex was 
responsible for the largest variance within each measure of sleep architecture. Men spent 
significantly less time in stages 3 and 4 of NREM, more time in lighter sleep of stages 1 
and 2, and have a higher likelihood of arousal at night.  There is a general assumption 
that the differences in sleep between male and female arise after puberty (“Sleep, Sex 
Differences, and Women‟s Health,” 2003). 
One study reported that women had significantly shorter circadian period relative 
to the intrinsic rhythm of melatonin and core body temperature. (J. F. Duffy et al., 2011). 
Cain et al. found in their study that the timing of the core body temperature and 
melatonin secretion was earlier in young women despite having the same sleep timing as 
men (Cain et al., 2010). Given that circadian rhythm and melatonin influence sleep 
 14 
structure, these findings present important implications for understanding sex differences 
in sleep timing and duration.  
Two studies reported women having higher baseline slow wave activity levels and 
a greater slow wave activity rebound after sleep deprivation (Armitage, Smith, 
Thompson, & Hoffman, 2001; Manber & Armitage, 1999). These differences between 
men and women in slow wave activity response may arise from a difference in the 
accumulation and dissipation of homeostatic sleep pressure. Several studies have shown 
that hormones affect properties of sleep, including spindle frequencies and slow wave 
activity  (Dzaja et al., 2005; Margaret L Moline, Broch, Zak, & Gross, 2003; Shechter & 
Boivin, 2010). The hormonal changes in the lives of healthy women are more dynamic 
than in men, which may explain the sex differences in circadian rhythm and sleep. There 
is a lack of conclusive evidence that controls for the complex hormone interactions of the 
human body to accurately explain these differences between men and women. 
 
Urine Production and Output 
Urine is produced to eliminate waste from the body, and also to maintain balance 
and composition of extracellular fluid. Water and sodium balance are two factors that 
influence urinary output by the kidney. In the normal kidney, the urine output can be 
diminished by concentrating urine by water reabsorption or sodium retention.  
Arginine vasopressin (AVP) is a water-conserving hormone that regulates body 
water retention. It is synthesized in the hypothalamus and released mainly when plasma 
osmolality increases. The target receptors for AVP are found in the distal tubules of the 
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kidney where it can influence urine concentration. AVP is released in response to 
environmental changes, which is characteristic of the reported diurnal rhythm by Rittig et 
al. (Rittig, Knudsen, Nørgaard, Pedersen, & Djurhuus, 1989). Their study showed that 
normal subjects had a significant increase in AVP levels during the night. 
Atrial natriuretic peptide (ANP) is released by the heart to control fluid 
homeostasis in response to high blood pressure. The atria release ANP to stimulate 
sodium secretion, and subsequently fluid secretion by the kidney. ANP inhibits the 
release of AVP and suppresses the effect of the renin-angiotensin system, and thus 
aldosterone (Bold, 1985). This peptide‟s inverse effect of the renin-angiotensin-
aldosterone system (RAAS) makes it a likely component in nocturia. The rhythm of ANP 
secretion has not been agreed upon, making it difficult to assess the specific influences of 
this hormone on nocturia (Elias, Antunes-Rodrigues, & Moreira, 1997; Follenius, 
Brandenberger, & Saini, 1992; Rittig et al., 1991). 
The renin-angiotensin-aldosterone system (RAAS) has a role in the conservation 
of sodium in the kidneys via the action of aldosterone (Boron, 2005). The kidney secretes 
renin when blood volume is low, which is converted into angiotensin I, then into 
angiotensin II. Angiotensin II promotes vasoconstriction and also stimulates the release 
of aldosterone. Aldosterone promotes sodium and water reabsorption in the kidney. The 
renin-angiotensin-aldosterone system has been shown to exhibit a diurnal rhythm. 
(Hurwitz, Cohen, & Williams, 2004). Renal sodium conservation is sensitive to 
environmental changes. 
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Overall, there are many hormones that affect urine output, and thus are important 
in understanding the etiology and treatment of nocturia. 
 
Day-night Variation of Urine Output 
Kirkland et al. reported that his young and elderly groups had similar 24 hour 
mean volumes of urine output, but the elderly group excreted more urine throughout the 
night than the young group (Kirkland, Lye, Levy, & Banerjee, 1983). Although the 
elderly group had approximately 30% less 24 hour sodium excretion than the young, they 
were still found to have a higher sodium excretion at night. Two other studies found that 
the elderly with nocturnal polyuria have almost twice as much of their 24 hour urine 
output at night relative to a control group (Hvistendahl, Frøkiaer, Nielsen, & Djurhuus, 
2007; Robertson et al., 1999). 
An earlier study revealed that posture plays a role in this day-night variation in 
urine output. In 1957, Thomas et al. showed that standing up from the recumbent position 
resulted in a decrease in urine, sodium, and chloride output, while the opposite was true 
for lying down (Thomas, 1957). They postulated that their findings are maintained by 
some hormonal mechanism. Gross later proved this to be the plasma renin angiotensin-
aldosterone system (Gross, 1958). Cohen et al. demonstrated that plasma renin levels are 
affected by posture (Cohen, Conn, & Rovner, 1967). The upright posture leads to a drop 
in the renal arterial pressure at the juxtaglomerular apparatus. This stimulates the release 
of renin, and subsequently stimulates the release of aldosterone to induce water and 
sodium retention. Their data also demonstrated that the change in renin activity is due to 
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the changes in level of enzyme rather than of other components of the RAAS. It is 
therefore important to control for posture when investigating urine output. 
Mills et al. conducted several studies in the 1970s to elucidate that the day-night 
variation in urine production is also influenced by an endogenous rhythm (Mills, Minors, 
& Waterhouse, 1978). In order to remove exogenous influences on a potential internal 
rhythm, food and fluid intake, posture, and lighting were all controlled for through a 
constant routine, while measuring urine production throughout the study. These measures 
were taken to distinguish a circadian rhythm from a diurnal rhythm. After controlling for 
exogenous influences, Mills et al. was able to show the circadian rhythmicity of urine 
output. Their findings indicated that urine output was the lowest at midnight, which 
supports Mills‟ earlier work. This rhythm in urinary output was found to similar to that of 
vasopressin (George et al., 1975). A similar pattern was found in atrial natriuretic 
peptide, a hormone that is found to be at maximum levels at midnight (Rittig et al., 1991). 
Without taking the same measures as Mills et al., these two hormones were identified to 
exhibit a diurnal rhythm, although whether they exhibit a true circadian rhythm could not 
be determined from the experimental procedures used.  
The day-night pattern of urine output plays an important role in nocturia. There is 
strong evidence for greater urine output at night among older people, and urine output is 
influenced by age, posture, and hormones. Each of these components should be 
considered when investigating nocturia. 
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Circadian Rhythm of Hormones Affecting Urine Output 
A study that grouped subjects into four different conditions found that the 
circadian rhythm in urine output is sensitive to both internal and external stimuli (Minors 
& Waterhouse, 1982). A clear circadian rhythm in urine composition and volume is 
reported in young subjects (Kamperis et al., 2004; Kawasaki et al., 1990).  The observed 
pattern of urine output is supported by the reported circadian rhythms of AVP, ANP, 
plasma renin activity (PRA), and aldosterone (Cugini et al., 1992a; Donckier, Anderson, 
Yeo, & Bloom, 1986; Maggioni, Lucini, Antinozzi, & Pagani, 2001; Mulrow & Ganong, 
1961; Portaluppi et al., 1990; Rittig et al., 1991). However, most of these studies could 
not verify a clear circadian rhythm because they did not control for sleep, posture, and 
other factors. A study by the Brandenberger group included both sleep deprivation and 
sleep shifting (to the daytime), and concluded a close link between aldosterone secretion 
and the sleep-wake cycle, rather than a circadian rhythm in aldosterone secretion 
(Charloux, Gronfier, Lonsdorfer-Wolf, Piquard, & Brandenberger, 1999). They found 
that aldosterone levels were significantly higher during sleep whether sleep occurred 
during the day or night. A later study by the same group found that sleep deprivation 
inhibits the increase in aldosterone levels during nocturnal sleep (Charloux et al., 2001). 
The presence of circadian rhythmicity in hormones affecting urine output has clear 
implications for nocturnal voiding. If secretion of a hormone exhibits a circadian rhythm, 
the hormone levels will vary with the time of day and will vary independent of postural 
changes, sleep-wake behavior, or day-night differences in activity. If secretion of a 
hormone shows day-night (diurnal) differences that are not circadian, the hormone levels 
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will change based on the behavioral and/or environmental differences between day and 
night, but under conditions where day-night differences in behavior (posture, activity 
level, sleep-wake state) or environment (light-dark) are controlled will not show such 
variation. Most reported hormone rhythms have not been investigated closely enough to 
distinguish between diurnal and circadian rhythms. It is difficult to treat nocturia without 
understanding the secretion patterns of hormones affecting urine output. 
 
Age-related changes in AVP  
  The diurnal rhythm of vasopressin is established during childhood, and nocturnal 
release becomes attenuated with age (Asplund & Aberg, 1991; Ouslander et al., 1998). 
The diurnal rhythm of vasopressin in young adults was found to be significantly higher at 
night (George et al., 1975). Several studies show that with age, the day and night time 
levels of vasopressin become similar due to the blunting or lack of nocturnal release 
(Asplund & Aberg, 1991; Forsling, Montgomery, Halpin, Windle, & Treacher, 1998; T. 
M. Johnson, Miller, Pillion, & Ouslander, 2003; Moon et al., 2004). Asplund found that 
the levels of vasopressin were similar in older subjects between those with and without 
nocturnal polyuria, suggesting that the underlying cause of nocturia may not directly be 
due to changes in AVP (Asplund, 2002). These age-related effects may be due to an 
inadequate renal tubular response to vasopressin (Miller, 2009). Higher urine output at 
night in older adults may be due to attenuation of AVP release or inadequate response to 
the hormone. 
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Age-related changes in ANP 
Johnston et al. suggested that the lower renin levels associated with age may be 
influenced by the rise in ANP with age (Johnston et al., 1989). Cugini et al. investigated 
the effect of aging on circadian rhythm of hormones by controlling for posture, lighting, 
and food and fluid intake (Cugini et al., 1992b). The overall levels of ANP in the older 
subjects were significantly higher than the young subjects. However, they report that the 
ANP circadian rhythm is lost in the elderly while aldosterone and renin rhythms were still 
detected, suggesting that the inhibitory action of ANP might be lost with age. These 
results suggest that the age-related increase of plasma ANP concentration contributes to 
the higher urine output at night.  
 
Age-related changes in the RAAS 
There are many studies that show that the RAAS system goes through age-related 
changes. Healthy subjects 85 years of age displayed significantly lower levels of plasma 
renin and aldosterone concentrations than normal 40 year old subjects (Skøtt, Ingerslev, 
Damkjaer Nielsen, & Giese, 1987). Several studies reported an age-related decrease in 
mean levels of plasma renin activity (Belmin, Lévy, & Michel, 1994; Cugini et al., 
1992b; Lall, Peshin, & Karmarkar, 1995; Schüssler et al., 2010). In one study, the 
observed differences with age were reported to be modest (Bauer, 1993). Reports of age-
related decrease in renin, angiotensin, and aldosterone concentrations may contribute to 
the higher urine output at night. 
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Sex Differences in ANP, AVP, RAAS 
Hvistendahl et al. found that young women had lower nocturnal levels of 
vasopressin compared to young men (Hvistendahl et al., 2007).  In another study, plasma 
vasopressin concentration was always higher in men than in women (Asplund & Aberg, 
1991).  The effect of sex hormones on AVP and water homeostasis was investigated by 
Graugaard-Jensen and colleagues (Graugaard-Jensen, Hvistendahl, Frøkiær, Bie, & 
Djurhuus, 2008). They reported that estrogen does not affect the daily rhythm of AVP, 
aldosterone, ANP, and subsequent urine output. Even without the effects of estrogen, a 
study by Stachenfeld et al. showing that women have higher renal sensitivity to AVP 
than men may explain the sex-related differences (Stachenfeld, Splenser, Calzone, 
Taylor, & Keefe, 2001). They also suggest that there is a change in the osmotic regulation 
during the menstrual cycle, possibly due to estrogen effects on AVP (Stachenfeld, Silva, 
Keefe, Kokoszka, & Nadel, 1999). Nocturia mainly affects older people, where the 
women are not having menstrual cycles, suggesting that there are other reasons that 
influence higher urine output. A greater sensitivity to vasopressin would promote water 
retention, which may contribute to possible sex differences in nocturia.  
An analysis of a reference sample of 911 healthy subjects taken from the 
Framingham Heart Study showed that higher ANP levels were found in females 
(Dawber, Meadors, & Moore, 1951; Wang et al., 2002). The results of several studies of 
patients with cardiovascular problems demonstrated this same pattern (Alehagen, 
Svensson, & Dahlström, 2007; Hogenhuis et al., 2005; Luchner et al., 2002). However, in 
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one study of 216 healthy subjects 20 to 77 years of age, there was no significant 
difference in the mean ANP value (Clerico et al., 2002). 
Several studies have reported that plasma renin activity is lower in women than in 
men (James et al., 1986; Kaplan et al., 1976; Sandberg & Ji, 2003; Schunkert et al., 1997; 
Schüssler et al., 2010). The down-regulation of the RAAS system by estrogen has been 
demonstrated more significantly through laboratory experiments, rather than in vivo 
(Fischer, Baessler, & Schunkert, 2002; McGuire, Watson, Pérez-Barriocanal, Fitzpatrick, 
& Docherty, 2007). One study found no significant sex-related differences in RAAS 
between 85 year old subjects (Skøtt et al., 1987). They suggested that this could be due to 
the lack of standardized methods to compare plasma hormone concentrations. 
There are observed sex differences in ANP, AVP, and RAAS. Females tend to 
have higher sensitivity to AVP and higher levels of plasma ANP. Males have higher 
levels of PRA and plasma AVP. The sex-related differences of these hormones that affect 
urine output suggest an unequal prevalence of nocturia. 
 
Nocturia and Sleep 
There are several factors of nocturia to consider. Diuretic medications and alcohol 
may aggravate nocturia (“Nocturia,” 2013). Congestive heart failure and sleep apnea are 
some of the many underlying medical problems that may exacerbate nocturia. After 
controlling for wake times, and fluid and food intake using a Constant Routine protocol, a 
significant difference in the circadian pattern of urine output was found between younger 
and older subjects (Hares et al., 2007). The greater amount of the 24 hour urine output at 
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night in the older group suggested that age-related changes in the circadian rhythm of 
some of the hormones involved in urine production may lead to nocturia. One candidate 
is AVP, due to the disturbance in the diurnal variation of AVP, which was found to be a 
common cause of nocturia (Asplund & Aberg, 1991). 
 
Nocturia and Aging 
Many studies have shown a higher prevalence of nocturia with age. Several 
urological survey studies have examined self-reports of nocturia in different age groups. 
The vast majority of the oldest age group in the population will wake up at least once per 
night to void, while fewer than 20% have no reported symptoms of nocturia (Fonda, 
2002). A study in Austria by Schatzl et al. found that the percentage of men and women 
that void two or more times per night consistently increases from 3% below 30 years to 
about 30% for those 60 years or older (Schatzl et al., 2000). Chute et al. investigated the 
prevalence of urinary symptoms of prostatism in a Minnesota community and found that 
nocturia increases with age  (Chute et al., 1993). These findings agree with the results of 
population studies conducted in Denmark and Japan (Jensen, Jørgensen, Mogensen, & 
Bille-Brahe, 1986; Tsukamoto et al., 1995). A study conducted in the Netherlands 
reported that nocturia is experienced by 62% of men 55-74 years of age, and by 80% of 
men older than 75 years, with similar findings in women (L. Van Dijk, Kooij, & 
Schellevis, 2002). Tikkinen et al. conducted a survey of 6,000 subjects in Finland from 
the ages of 18-79 and reported that the prevalence of at least 2 voids per night was less 
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than 10% for age 18-49, then more than doubles after age 60 (Tikkinen, Tammela, 
Huhtala, & Auvinen, 2006). 
Individuals seem to be more affected by nocturia as they get older. Regular 
complaints of nocturia were reported by 4% of children aged 7–15,  more than 55% for 
men and women aged 50–59, and 91% of men and 72% of women over 80 years 
(Mattsson, 1994; Middelkoop, Smilde-van den Doel, Neven, Kamphuisen, & Springer, 
1996). Saito et al. found that in their study group elderly patients were more likely than 
the younger patients to have problems leading to nocturia (Saito, Kondo, Kato, & 
Yamada, 1993). While the 24 hour urine volumes were similar, the elderly had a lower 
daytime urine output and greater nocturnal urine output, with more frequent and smaller 
nocturnal voids. This might be explained by age-related changes in the urinary system, 
such as decreased functional bladder capacity (Asplund, 1999), increased post-residual 
urine volume (Madersbacher et al., 1998), and changes in the detrusor muscle (Elbadawi, 
Yalla, & Resnick, 1993).  
 
Nocturia and Gender 
Another factor to consider in nocturia is gender. There are physiological 
differences between men and women, some of which also affect the aging process. A 
survey of over 2,500 people in Austria showed that men and women are almost equally 
affected by nocturia (Schatzl et al., 2000). Jin and Moon found an insignificant difference 
in the prevalence of nocturia between men and women (Jin & Moon, 2008). A study by 
Middelkoop et al. reported that men had a greater prevalence of nocturia than women 
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after the age of 50 (Middelkoop et al., 1996). Of the 6,000 participants surveyed, 
Tikkinen reported that the prevalence of nocturia in women is higher than men from the 
ages of 18 to 49, similar from the ages of 50-59, and higher in men from the ages of 60-
79 (Tikkinen et al., 2006). The direct link of gender and nocturia is unclear, suggesting a 
greater need to elucidate the underlying mechanisms of nocturia. 
 
Role of Nocturia in Quality of Life 
Nocturia can reduce the hours of uninterrupted sleep at night, leading to more 
daytime sleepiness. Two surveys have found a high correlation between the self-reports 
of waking at night to void with symptoms of excessive daytime sleepiness (Daniel J 
Foley et al., 2007; Whitney et al., 1998). Nocturia can also lead to increased risk of injury 
from falling at night, depressive symptoms, and memory problems (Marinkovic, Gillen, 
& Stanton, 2004). There are even reports that survival rates are lower in individuals with 
nocturia (Varilla, Samala, Galindo, & Ciocon, 2011).  
Nocturia has been reported as major cause of sleep disruption in sleep surveys. 
The 2003 National Sleep Foundation “Sleep in America” polled more than 1,500 
American adults over the age of 55 (“Executive Summary of the 2003 Sleep in America 
poll,” 2003). The most common reported problem disturbing sleep of adults ages 55-84 is 
the need to get up to go to bathroom (Figure 3). Most reported experiencing this every 
night or almost every night. The report showed that the need to get up increases 
significantly with age. Nocturia was reported to be the second strongest predictor for self-
reported poor sleep quality, and represented a 75% increased risk of self-reported 
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insomnia after correcting for significant co-morbidities (D. Bliwise et al., 2004). The 
Cardiovascular Health Study surveyed over 4,500 people over the age of 65 to describe 
the prevalence of daytime sleepiness in the elderly. About two-thirds of those surveyed 
(68% of women and 66% men) reported often waking up several times a night. The most 
prevalent reason of waking up was to go to the bathroom (89% men and 86% women) 
(Whitney et al., 1998). Improving the symptoms of nocturia have shown to improve the 
quality of life (Johnson et al., 2003).  
  
 27 
 
    
 
Figure 3 – Symptoms Disturbing Sleep of Older Adults. Various causes of sleep 
disturbance of adults over the age of 55, with nocturia reported as the most common 
problem. Adapted from the 2003 Sleep Poll. 
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Chronic lack of sleep has many detrimental effects on the quality of life. Studies 
of people suffering from insomnia demonstrated how daytime performance declines, 
while medical illness and hospitalizations increase (Culpepper, 2006; Stanley, 2005). 
When nocturia is a comorbidity of insomnia, the impairments were larger (Hernández 
Fernández, Ristol Pont, Estivill, Batista Miranda, & López Aramburu, 2007; Hetta, 1999; 
Stanley, 2005). The prevalence of nocturia increases as comorbidities with conditions 
such as sleep disorders and obesity. A recent study of patients in the Boston area reported 
that nocturia is associated with a decreased quality of life and increased symptoms of 
depression (Kupelian et al., 2012). Asplund studied over 10,000 elderly and found that 
those with more than two nocturnal voids per night were more likely to have poor sleep, 
have cardiovascular disease and be diabetic (Asplund, 2006a). In an earlier study, 
Asplund found that the mortality rate of older people correlated with the number of 
nocturnal voiding episodes over a 4.5 year window of observation (Asplund, 1999). 
Reports of impaired quality of life was reported in 66.9% of women and 62.2% of men 
with nocturia (Schatzl et al., 2000). 
Daytime impairment often affects occupational performance. Kobelt et al. have 
reported that those with nocturia had greater work impairment, which was significantly 
correlated with the severity of the condition (Kobelt, Borgström, & Mattiasson, 2003). 
Ohayon found that there were significantly more sick days for those waking up at least 
one night per week (Ohayon, 2008). Disturbance of sleep due to nocturia negatively 
affects work attendance and performance. Participants of one study reported more 
daytime sleepiness with more sleep disturbances (Whitney et al., 1998). Akerstedt et al. 
 29 
found that the likelihood of involuntarily falling asleep at the workplace is connected to 
disturbed sleep at night (Akerstedt et al., 2002).  
Many studies have shown that sleep disruption, such as with nocturia, have led to 
more accidents. Nocturia may cause fatigue in drivers, which is estimated to contribute to 
about 35% of accidents on the road after moderate sleep deprivation (Williamson & 
Feyer, 2000). Furthermore, older people with nocturia have a higher probability of 
falling, which might be due to going to the bathroom at night, or to daytime sleepiness 
(Nakagawa et al., 2008). A high percentage of elderly patients fall during their effort to 
void at night (Barker & Mitteness, 1988). One study showed a significant positive 
association between the number of voids per night and the prevalence of bone fracture 
(Asplund, 2006b). Another study found that the risk of hip fractures increases in men 
with nocturia independent of age (Schatzl et al., 2000). 
 
 Treatment of Nocturia  
The current treatments available for nocturia depend on the etiology of the 
condition. Controlling fluid intake prior to bedtime is one of the many lifestyle changes 
that can reduce the symptoms of nocturia. Surgery is generally used when a significant 
causative factor of nocturia is the prostate or other anatomical pressures to void (Jin & 
Moon, 2008).  
Generally, the easiest step to take is a change in lifestyle. Nocturia due to caffeine 
and alcohol can be avoided if these diuretics are restricted (Abrams et al., 2002). 
Restricting fluid intake before bedtime helps particularly for incontinence due to a strong 
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urge to void (Griffiths, McCracken, Harrison, & Gormley, 1992). However, a study by 
Asplund and Aberg have found that about half of those who woke up more than two 
times per night had already restricted their fluid intake (Asplund & Aberg, 1992). It 
seems, though, that fluid restriction is ineffective for cases of nocturnal polyuria and 
lower extremity edema (Jin & Moon, 2008).  The edema in the leg may be responsible for 
the fluid retention that leads to nocturia (Laureanno & Ellsworth, 2010). Compression 
stockings are used to limit fluid retention in the lower extremities. Lifestyle changes 
might also include behavioral modification. Behavioral therapies primarily focus on 
alleviating bladder symptoms with bladder health promotion, and training to control 
bladder functions (Wyman, Burgio, & Newman, 2009). Evidence for pelvic floor muscle 
exercise and urge suppression is positive (Burgio, 2004; Burgio et al., 2002; Teunissen, 
de Jonge, van Weel, & Lagro-Janssen, 2004). Cho et al created an educational program as 
behavioral therapy that showed significant improvement of nocturia after the first 
behavioral modification program (Cho et al., 2012). Lifestyle interventions prevent 
mostly external influences on nocturia, which would not be effective for underlying 
causes like altered circadian rhythms. The most investigated and common treatment for 
nocturia, however, is pharmacotherapy. 
The FDA has not approved any treatments directly for nocturia at this time. Still, 
there are a number of pharmacological interventions used to treat the symptoms of 
nocturia. Some of the more known pharmacological therapy for nocturia primarily target 
bladder capacity and urinary flow obstruction (T. Johnson, 2013). Bladder outlet 
obstruction can be alleviated by relaxing muscles with alpha blockers, which target the 
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alpha-1 receptors found in the prostate and base of bladder (“Alpha-blocker medications 
for prostatitis,” 2010). If the obstruction is in the urinary tract, 5-alpha-reductase activity 
is inhibited (“Alpha-blocker medications for prostatitis,” 2010). The type 2 form of 5-
alpha-reductase is an enzyme that catalyzes the conversion of testosterone to 
dihydrotestosterone, which is primarily responsible for prostate development and a factor 
of benign prostatic hyperplasia (Steers, 2001). Johnson et al. found that alpha blockers 
for bladder outlet obstruction that less than 40% of the men having a 50% reduction in 
nocturia, and for urinary tract obstruction that the net benefits for nocturia to be small (T. 
M. Johnson 2nd et al., 2003, 2007). When nocturia is caused by detrusor overactivity, an 
anticholinergic medicine can be prescribed to relieve the muscle spasms (“Nocturia,” 
2013). One study shows a significant improvement in sleep with a significant reduction in 
waking up to void (Hill, Khullar, Wyndaele, & Lheritier, 2006). The efficacy of 
anticholinergic therapy for detrusor overactivity has been shown in over 6,700 patients 
across over 50 studies (Hay-Smith, Herbison, Ellis, & Moore, 2002; Hill et al., 2006). 
However, Fitzgerald‟s group found that anticholinergics were not effective in treating 
urge incontinence (Fitzgerald, Lemack, Wheeler, & Litman, 2008). Their conclusion 
points to the importance of determining the correct etiology of nocturia to properly treat 
the condition. Studies have shown that anticholinergics have insignificant benefits for 
nocturia, but may be more useful in combination with another drug (Ruggieri, 
Braverman, & Pontari, 2005). 
Desmopressin is similar to vasopressin, with only two amino-acid substitutes, and 
is found to be effective and well-tolerated treatment for both men and women for 
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nocturnal polyuria (G Lose et al., 2004; Gunnar Lose, Lalos, Freeman, & van 
Kerrebroeck, 2003; Mattiasson, Abrams, Van Kerrebroeck, Walter, & Weiss, 2002). As 
an analogue of arginine vasopressin (AVP), desmopressin increases water reabsorption in 
the kidney, thus decreasing urine output. This synthetic hormone can help treat the 
diminished release of vasopressin in nocturnal polyuria, and protect against the increase 
in ANP with sleep (Ancoli-Israel, Bliwise, & Nørgaard, 2011). Asplund et al. have 
shown that reducing the frequency of nocturnal voids with desmopressin led to 
significantly more hours of undisturbed sleep (Figure 4) (Asplund, Sundberg, & 
Bengtsson, 1999). During a double-blind treatment phase of a study done by van 
Kerrebroeck et al., there was a significant increase in the duration of sleep time and 
reduction in nocturia frequency with desmopressin (Van Kerrebroeck et al., 2007). While 
the efficacy of desmopressin is strongly supported, the significance is highly specific to 
nocturnal polyuria. 
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Figure 4 – The Number of Nocturnal Voids After 2 Weeks of Desmopressin 
Treatment. Reproduced from (Ancoli-Israel et al., 2011). 
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It is important to know the etiology of nocturia to administer the correct 
treatments. Despite the convenience of behavioral and lifestyle treatments, these methods 
are not the most effective. Some pharmacological interventions are more effective 
because they directly treat the underlying cause. Yet treatments are not FDA approved for 
directly curing nocturia because some potential underlying causes of nocturia, such as 
disrupted sleep or altered circadian rhythmicity, have not been directly addressed as 
causes of nocturia. Another question to consider when treating nocturia is whether the 
patient is awoken at night by the urge to void or instead if the patient decides to void after 
waking up. Older people, who typically have lighter and more fragmented sleep, may 
awaken first and then decide to void. A few studies took this into consideration by 
targeting the brain to treat sleep fragmentation as a factor in nocturia. One study found 
that combining an alpha-blocker with a hypnotic medication was more successful in 
reducing reported nocturia frequency than just the alpha-blocker alone (Song & Ku, 
2007). A study by Sugaya et al. found that walking exercise significantly decreased the 
number of nocturia episodes due to deepened sleep (with that deepened sleep likely 
raising the bladder arousal threshold) (Sugaya et al., 2007). While limited in evidence, 
these two studies recognized the need for further investigation of the factors contributing 
to nocturia. With a better understanding of the underlying causes of nocturia, clinicians 
can then more effectively treat nocturia.  
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Specific Aims 
One of the most common causes of sleep disturbance is nocturia. Many studies 
show that the tendency to void during the night increases with age, and is affected by the 
sex of the individual. What remains uncertain is the etiology of these age- and sex-related 
differences. The prevalence of nocturia in literature has been inconsistently explained in 
the significance of day-night rhythms of diuretic and anti-diuretic hormones affecting 
urine output. What has been overlooked in much of the literature is the connection 
between nocturia and age- and sex-related changes in sleep and circadian rhythms.  
Therefore, the aims of this study are to determine: 
1.  whether there is an association between urological complaints and sleep complaints in 
older men and women, and whether those complaints differ between older men and 
women. We will accomplish this by surveying patients visiting the Brigham and 
Women‟s Hospital Department of Urology clinic. We will analyze the responses and 
investigate if there are sex- or sleep-related associations with urological complaints; 
2.  whether there is evidence for a circadian rhythm in any of the diuretic/anti-diuretic 
hormones that may contribute to day-night differences in urine output, and if any of those 
rhythms are altered with aging thus potentially contributing to nocturia. We will 
accomplish this by analyzing hormone data collected from young and older participants 
in an inpatient circadian rhythm study in Brigham and Women‟s Hospital Division of 
Sleep Medicine. We will determine if a circadian rhythm is exhibited by these hormones, 
and if any age-related differences in the pattern of hormone release are present. 
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This study is designed to investigate the sleep disturbance symptoms, as well as 
circadian rhythms of hormone levels that might contribute to nocturia. These results 
could provide evidence for a new pathophysiological approach to relieve nocturia, 
contribute to the ongoing research in the urology and circadian rhythm fields, and 
increase awareness of a condition that can affect the quality of life of older adults. 
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METHODS 
Questionnaire Study 
Subjects in the questionnaire study were patients, 204 males (64.2±8.84 years) 
and 87 females (63.3±8.95 years), who were ≥50 years old with appointments at the 
Brigham and Women‟s Hospital Division of Urology clinic. After arriving for their 
previously-scheduled appointment, the subjects were approached and asked to participate 
in the questionnaire study. Written consent was obtained from each participant. The 
protocols, which conform to the Declaration of Helsinki, were approved by the Human 
Research Committee at Partners HealthCare System. 
Subjects were given four questionnaires: the Pittsburgh Sleep Quality Index 
(Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) to measure subjective sleep quality 
from the past month, the Epworth Sleepiness Scale (Johns, 1991) to evaluate daytime 
sleepiness, the AUA Symptom Index (AUASI) (Barry et al., 1992) to evaluate urinary 
complaints, and a general questionnaire regarding health, naps, and medication. The 
questionnaires were scored according to published criteria. Higher scores on each of the 
questionnaires [PSQI, ESS, AUASI] indicate greater numbers of complaints. 
The mean age of the men and women were compared using a t-test to determine 
whether their ages were significantly different. The link between urological complaints, 
daytime sleepiness, and sleep quality was investigated by analyzing questionnaire 
responses. The mean scores of the PSQI, ESS, and AUASI questionnaires were compared 
by conducting Levene‟s Test for equality of variances and a t-test for equality of means 
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to investigate any sex-related differences in reported quality of sleep, daytime sleepiness, 
and urological complaints. 
Spearman‟s correlation coefficient was used to explore the association between 
sleep–wake (daytime sleepiness and quality of sleep) and urological complaints. First, the 
PSQI and ESS questionnaire scores were compared with AUASI questionnaire scores to 
investigate how sleep or daytime sleepiness impacts urological symptoms. Then, the 
PSQI questionnaire scores were compared with ESS questionnaire scores to identify any 
associations between sleep quality and daytime sleepiness.  
The relationship between test scores was quantified with a multivariate linear 
regression analysis. The extent of how well one questionnaire can predict the results from 
the two others was tested. Statistical tests were run using SPSS® software. 
 
Hormone Study 
Subjects in the hormone study were ten young (9M, age: 23.1±2.81) healthy 
individuals who were ≥18 years old, and nine older (6M, age: 58.9±4.65) healthy 
individuals who were 55 – 80 years old, who were screened to participate in a research 
study at Brigham and Women‟s Hospital Division of Sleep Medicine. In both age groups, 
those with sleep, psychiatric, or active medical disorders were excluded. Subjects were 
recruited by ads in flyers, newspapers, and on the web. Written informed consent was 
obtained from each participant. The protocols, which conform to the Declaration of 
Helsinki, were approved by the Human Research Committee at Partners HealthCare 
System. 
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Subjects had three baseline days to adjust to the laboratory environment, and then 
underwent a constant routine (CR) circadian phase and amplitude assessment procedure. 
The baseline days consisted of 16 hours of wakefulness and 8 hours of time in bed in the 
dark, scheduled at each person‟s habitual times. The CR began at wake time after the 
third night, and consisted of continuous wakefulness, in constant dim light (3 lux), in a 
controlled and constant posture (head of bed elevated to ~45° with knees raised), low 
activity level, constant room temperature (~75° Fahrenheit), a time-free environment, 
food and liquid in equicaloric hourly aliquots throughout day and night, and collection of 
blood, saliva and urine samples at regular intervals. A trained staff member remained in 
the room with the participant throughout the CR to ensure they followed the protocol 
instructions and to assist them in remaining awake. In the young group, the CR lasted for 
40 hours, while in the older group it lasted 27 hours.  
The meals for baseline days were ad lib with 16 oz. water provided with each 
meal. The older subjects were allotted 150 mEq Na
+
/100 mEq K
+
 (± 20%) controlled 
nutrient, isocaloric diet, and 2500 mL fluids for each meal on their third baseline day. 
During the constant routine, the participants received hourly meals that provided 150 
mEq Na
+
/100 mEq K
+
 (± 20%) controlled nutrient, isocaloric diet, and 2500 mL fluids 
each 24 hours.  The participants were required to eat all the food and drink all the fluids 
during the CR.  
Blood samples were collected every four hours from the young and older subjects 
throughout the CR. The blood samples were immediately processed and frozen, and later 
assayed for aldosterone, AVP, ANP, and PRA. 
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Plasma aldosterone was measured by a radioimmunometric assay (RIA) with the 
Coat-A-Count procedure through Siemens Medical Solutions Diagnostics. The sensitivity 
of this method is 11 pg/mL. The intra-assay precision is 3.3% and the inter-assay 
precision is 8.4%. 
Plasma ANP was measured by an RIA kit manufactured by the American 
Laboratory Products Company. The sensitivity of this method is 3.5 pg/mL. The intra-
assay precision is 8.6% and the inter-assay precision is 11.6%. 
Plasma AVP was measured by double anti-body RIA with the Buhlmann 
Vasopressin RIA “Ultra Sensitive” and Direct RIA kits manufactured by the American 
Laboratory Products Company. For Direct RIA, the sensitivity is 0.75 pg/mL, the intra-
assay precision is 6.0%, and the inter-assay precision is 9.9%. For RIA “Ultra Sensitive”, 
the sensitivity is 0.39 pg/mL, the intra-assay precision is 7.6%, and the inter-assay 
precision is 10%. 
Plasma renin activity was measured by an RIA kit manufactured by Diasorin, Inc. 
The intra-assay variation is 4.6-10%, and the inter-assay variation is 5.6-7.6%. The 
sensitivity is not reported. 
We averaged the plasma hormone data across participants in each age group in 4-
hour bins and plotted them to visually inspect whether there was any apparent 
rhythmicity. To confirm whether a significant circadian rhythm was present, we 
performed cosinor analysis using SAS® software. 
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RESULTS 
Questionnaire Study 
The groups of men and women were not significantly different in age (See Table 
1 and Figure 5).  
Table 1 –Age and Questionnaire Scores of Females and Males. N = number of 
subjects, SD = Standard Deviation, PSQI = Pittsburgh Sleep Quality Index, ESS = 
Epsworth Sleepiness Scale, AUASI = American Urological Association Sleep Index. 
  N Age SD PSQI SD ESS SD AUASI SD 
Female 87 63.27 8.95 7.21 4.84 5.91 4.75 14.83 10.0 
Male 204 64.17 8.84 5.26 3.43 5.94 4.31 11.73 7.97 
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Figure 5 – Mean Age of Males versus Females. Age of males on the left and of females 
on the right.  
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The mean PSQI score for the men was 5.26±3.43 and for women was 7.21±4.84 
(See Table 1 and Figure 6). An equality of variance test showed that the variability 
between mean PSQI scores of men and women were significantly different (p < 0.01). A 
two-tailed t-test with unequal sample variances showed that the mean PSQI scores were 
significantly higher in the women than in the men (p < 0.01), indicating greater sleep 
complaints in the women. See Table 2.  
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Figure 6 – Mean PSQI Scores of Males Versus Females. PSQI scores of males on the 
left and of females on the right. Females have significantly greater variability and a 
significantly higher mean score than males, indicating greater sleep complaints. 
 43 
The mean ESS score for males was 5.94±4.31 and for females was 5.91±4.75 
(See Table 1 and Figure 7). An equality of variance test showed that the variability 
between mean ESS scores of men and women were not significantly different (p = 0.258). 
A two-tailed t-test with equal sample variance showed that the mean ESS scores between 
men and women were not significantly different (p = 0.969). See Table 2. 
 
 
 
 
Figure 7 – Mean ESS Scores of Males Versus Females. ESS score of males on the left 
and of females on the right. Mean scores and variability were not significantly different 
between the two groups.  
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The mean AUASI score for males was 11.7±7.97 and for females was 14.83±10.0 
(See Table 1 and Figure 8). An equality of variance test showed that the variability 
between mean AUASI scores of men and women were significantly different (p < 0.01). 
A two-tailed t-test with unequal sample variance showed that the mean AUASI scores 
were significantly greater in the women than in the men (p = 0.012), indicating that the 
women had more urological complaints. See Table 2.  
 
Figure 8 – Mean AUASI Scores of Male versus Female. AUASI score of males on the 
left and of females on the right. Females had significantly greater variability and a 
significantly higher mean score than males, indicating greater urological complaints. 
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Table 2 – Test for Equality of Variances and Equality of Means between Genders of 
PSQI, ESS, and AUASI Scores. The variability between mean PSQI scores of men and 
women were significantly different. The variability between mean ESS scores of men and 
women were not significantly different. The variability between mean AUASI scores of 
men and women were significantly different. 
 F Sig. t df 
PSQI 15.84 0.000 -3.402 124.47 
ESS 1.282 0.258 0.039 289 
AUASI 8.271 0.004 -2.56 134.755 
 
A Spearman‟s rank-order correlation coefficient was computed to further assess 
the relationship between sleep quality, daytime sleepiness, and urological complaints 
among the women (Table 3). There was only a weak, positive correlation between PSQI 
and AUASI questionnaire scores (see Figure 9), suggesting that poorer sleep quality was 
associated with more urological complaints in the women. There was no significant 
correlation found between ESS and AUASI questionnaire scores, suggesting that daytime 
sleepiness was not associated with urological complaints. There was no significant 
correlation found between PSQI and ESS questionnaire scores either, suggesting that 
sleep quality was not associated with daytime sleepiness.  
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Table 3 – Spearman’s Correlation Coefficient between PSQI, ESS, and 
AUASI in Women. There was no significant correlation between sleep 
quality and daytime sleepiness, and daytime sleepiness and urological 
complaints.  There was a significant correlation between sleep quality and 
urological complaints.  
  PSQI ESS AUASI 
Spearman's 
rho 
PSQI 
Correlation 
Coefficient 
1 0.007 .325
*
 
Sig. (2-tailed) . 0.949 0.002 
N 86 86 86 
ESS 
Correlation 
Coefficient 
0.007 1 0.028 
Sig. (2-tailed) 0.949 . 0.797 
N 86 86 86 
AUASI 
Correlation 
Coefficient 
.325
*
 0.028 1 
Sig. (2-tailed) 0.002 0.797 . 
N 86 86 86 
* = p < .01      
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Figure 9 – Female AUASI Scores Plotted Against PSQI Scores. There is a positive 
correlation between PSQI and AUASI scores in females. 
 
Multivariate linear regression modeling found that when the PSQI score increased 
by 1 in women, the AUASI score increased by a mean value of 0.154 [t(84) = 3.0628, p = 
0.003]. When the AUASI score increased by 1 in women, the PSQI score increased by 
mean value of 0.660 [t(84) = 3.0628, p = 0.003]. See Table 5 and Figure 9. In women, 
urological complaints are a stronger predictor of sleep quality than vice versa. 
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Table 4 – Descriptive Statistics of Multivariate Linear Regression Modeling in 
Women. The overall fit model predicting PSQI scores significantly shows that ESS and 
AUASI scores can account for 10.2% of the variance in PSQI scores. The overall fit 
model predicting AUASI scores significantly showed that PSQI and ESS scores can 
account for 10.2% of the variance in AUASI scores. The overall fit model predicting ESS 
scores did not significantly show that PSQI and AUASI scores can account for the .1% of 
the variance in ESS scores.  
Female 
  
Unstandardized Coefficients 
(B) of Predictor Variables Overall Fit 
  PSQI ESS AUASI R
2
 F 
PSQI   0.017 0.154* 0.102 4.719* 
ESS 0.019   0.011 0.001 0.05 
AUASI 0.660* 0.045   0.102 4.728* 
* = p < .05      
 
    
   
A Spearman‟s rank-order correlation coefficient was computed to further assess 
the relationship between PSQI, ESS, and AUASI scores among the men (Table 5). There 
was a positive correlation between PSQI and AUASI questionnaire scores, ESS and 
AUASI questionnaire scores, PSQI and ESS questionnaire scores in men. Decreased 
quality of sleep reported through PSQI was correlated with increased daytime sleepiness 
in males. Increased daytime sleepiness was correlated with increased urological 
complaints in males. Decreased quality of sleep was correlated with increased daytime 
sleepiness in males. 
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Table 5 – Spearman’s Correlation Coefficient between PSQI, ESS, and 
AUASI in Men. There was a significant correlation between sleep quality 
and daytime sleepiness, sleep quality and urological complaints, and 
daytime sleepiness and urological complaints. 
  PSQI ESS AUASI 
Spearman's 
rho 
PSQI 
Correlation 
Coefficient 
1.00 0.266* .339* 
Sig. (2-tailed) . 0.000 0.000 
N 203 203 203 
ESS 
Correlation 
Coefficient 
0.266* 1.00 0.233* 
Sig. (2-tailed) 0.000 . 0.001 
N 203 203 203 
AUASI 
Correlation 
Coefficient 
.339
*
 0.233* 1.00 
Sig. (2-tailed) 0.000 0.001 . 
N 203 203 203 
*= p < .01      
 
 
Multivariate linear regression modeling found that the PSQI score increased by 1 
in men, the ESS score increased by a mean value of 0.293 [t(201) = 3.248, p = 0.001] and 
the AUASI score increased by a mean value of  0.723 [t(201) = 4.542, p = 0.000]. For 
each ESS score increased by 1 in men, the PSQI score will increase by a mean value 
of .171 [t(201) = 3.248, p = .001]. For each AUASI score increased by 1 in men, the 
PSQI score will increase by a mean value of .129 [t(201) = 4.542, p = .000]. See Table 6 
and Figure 10, 11. In men, sleep quality is a stronger predictor of daytime sleepiness and 
urological complaints than vice versa. 
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Figure 10 – Male PSQI Scores Plotted Against ESS Scores. 
 
 
Figure 11 – Male PSQI Scores Plotted Against AUASI Scores.  
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Table 6 – Descriptive Statistics of Multivariate Linear Regression Modeling in Men. 
The overall fit model predicting PSQI scores significantly shows that ESS and AUSI 
scores can account for 16.2% of the variance in PSQI scores in men. The overall fit 
model predicting ESS scores significantly shows that PSQI and AUASI scores can 
account for 8.9% of the variance in ESS scores in men.  The overall fit model predicting 
AUASI scores significantly shows that PSQI and ESS scores can account for 13% of the 
variance in AUASI scores in men. 
Male 
  
Unstandardized Coefficients 
(B) of Predictor Variables Overall Fit 
  PSQI ESS AUASI R
2
 F 
PSQI   0.171* 0.129* 0.162 19.34* 
ESS 0.293*   0.121 0.089 9.728* 
AUASI 0.723* 0.116   0.130 14.981* 
* = p < .05      
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Hormone Study  
The plasma hormone data were averaged into 4 hour bins and plotted. We 
detected an apparent rhythmicity in the young subjects (Figure 12). There was a decline 
in hormone levels from wake time (0h) to 16h awake, corresponding to the usual waking 
day. Then the levels rose throughout the nighttime and began to decline again at 
approximately 24h awake, corresponding to usual wake time. The 40h point was omitted 
from the dataset because some of the samples were collected after bedtime, and not 
during the CR.   
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Figure 12 – Mean Plasma Aldosterone Levels in Young Subjects. The plasma 
aldosterone concentrations in young subjects were recorded during their 40 hour constant 
routine.  
 
We did not detect any apparent rhythmicity in the older subjects (Figure 13). 
There was a decline from wake time (0h) to 12h awake, corresponding to the usual 
waking day. Then the levels rose to 16h awake, which still corresponds to the usual 
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waking day.  The levels fell until 20h awake, corresponding to the usual nighttime. The 
levels rose back up until 24h awake, which begins the usual wake time. 
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Figure 13 – Mean Plasma Aldosterone Levels in Older Subjects.  The plasma 
aldosterone concentrations were recorded in older subjects during their 27 hour constant 
routine. 
 
Cosinor analysis was performed on the aldosterone data to check the significance 
of any present circadian rhythm. The rhythm of young subjects fit to the cosine model, 
and thus demonstrated a significant circadian rhythm (F2,7 = 16.204, p < 0.01). The 
rhythm of older subjects did not significantly fit to the cosine model, and thus did not 
demonstrate a significant circadian rhythm (F2,7 =  2.10, p = 0.238). 
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DISCUSSION 
Questionnaire Study 
The mean age between men and women was not significantly different. This 
suggests that in our study, we did not have to consider the confounding influence of age 
in our analysis. 
The PSQI quantifies subjective reports of sleep quality. Studies show that men 
have a higher likelihood of arousal at night and women having higher baseline SWA 
levels. This suggests that men would have lower quality of sleep, yet our data shows 
women scoring higher on the PSQIs, indicating greater sleep complaints. This agrees 
with studies that show that women tend to report greater sleep disturbances than age-
matched men (M V Vitiello, 2000; Michael V Vitiello, Larsen, & Moe, 2004), and even 
when their objective sleep appears to be of better quality. Future studies interested in 
these results should refer to previous studies that have already compared the subjective 
reports with objective sleep measures, such as SWA and REM. 
The ESS characterizes daytime sleepiness. We found that daytime sleepiness 
reports were not significantly different between men and women. Without specifying the 
conditions for each question, it is difficult to ascertain whether the events coincide with 
the strong sleep drive in the afternoon. Furthermore, daytime sleepiness can be caused by 
poor sleep from the previous night, may change the sleep quality of the night of, or may 
be influenced by physiological disturbances.  
Nocturia was commonly characterized as a condition only found in men and 
related to BPH. Now it is well accepted that nocturia is found in both men and women. 
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Studies have reported that older women have higher prevalence of nocturia than men in 
the same age group. Based on the AUASI scores, we found that women had significantly 
more urological complaints than men in our study. Further analysis of the questionnaire 
results should be conducted to understand whether the women in our study had more 
chronic medical conditions, were taking medications, were pregnant, or had other reasons 
for having greater urological complaints than the men.    
PSQI score was a stronger predictor of AUASI score than vice versa in both men 
(.723 > .129) and women (.66 > .154) – a correlation stronger in men than in women 
(.723 > .66). This may mean that men have lighter sleep, and thus are more vulnerable to 
nocturnal voiding problems. In general, older men spend less time in the deepest stages of 
sleep than do older women, which may have contributed to the greater sleep disturbances 
reported here (Redline et al., 2004; Sheldon, Ferber, & Kryger, 2005). This would agree 
with our finding of how AUASI scores are stronger predictors of PSQI scores in women 
than in men (.154 > .129). Prior studies suggest that women have higher sensitivity to 
AVP and have higher levels of plasma ANP, which would contribute to greater urine 
output. Stronger hormonal influences to void may explain why urological complaints are 
stronger predictors of sleep quality in women than in men. Despite finding a correlation 
between sleep quality and urological complaints, we could not determine whether being 
awakened at night is due to poor sleep quality or the urge to void. Future studies should 
be conducted to determine if voiding follows awakening, or vice versa. 
We found that male PSQI scores predict ESS scores better than vice versa (.293 > 
.171). Poor sleep quality influencing daytime sleepiness agrees with the scientific 
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literature. Because we found this correlation only in men, this might suggest that men are 
more prone to the consequences of drowsiness during the day. It is also important to note 
the direction of prediction. Daytime drowsiness did not predict poorer sleep quality, 
which supports the literature of sleep fragmentation causing drowsiness the next day. A 
well-reported cause of interrupted sleep is urinary dysfunction. Our finding of daytime 
sleepiness prediction only in men might indicate that men are more affected by their 
urological complaints, and thus have a greater tendency to report it. 
In our study, we did not find a significant correlation of ESS scores with PSQI or 
AUASI scores in women. This might be due to the smaller sample size (87F versus 204 
M). By increasing the number of female respondents in the future, one might find 
daytime sleepiness associated with sleep quality or urological complaints, and may be 
more closely investigated. 
 
Hormone Study 
We found a circadian rhythm of aldosterone that is independent of sleep in young 
adults. While this agrees with the general literature, it is important to note the present 
results disagree with the results from one particular study. Brandenberger‟s group 
reported that the diurnal rhythm in aldosterone secretion is dependent on sleep, rather 
than an endogenous circadian rhythm (Charloux et al., 2001; Charloux, Gronfier, 
Lonsdorfer-Wolf, Piquard, & Brandenberger, 1999). Their study design differed from 
ours, in that subjects were either sleep-deprived or had their sleep shifted to daytime 
hours. Their study may not have adequately controlled for all the influences on circadian 
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rhythms. In contrast, our study subjects followed a Constant Routine for at least 24 hours, 
with controlled fluid and food intake spread throughout day and night, constant posture, 
lighting, room temperature, and wakefulness.  A Constant Routine protocol minimizes 
various exogenous effects to more accurately observe the output of the internal clock 
(Duffy & Dijk, 2002; Minors & Waterhouse, 1984).  While we did observe a circadian 
rhythm of aldosterone secretion in young subjects, we cannot determine why there was an 
absence of a circadian rhythm in older subjects. It may be due to the shorter duration of 
sample collection in the older subjects, due to the different sex distribution of the two age 
groups, or possibly due to an age-related attenuation of nocturnal aldosterone secretion 
(Asplund & Aberg, 1991; Ouslander et al., 1998). If the latter is the case, then the 
observed circadian rhythm of aldosterone in the younger subjects and absence in the 
older subjects may explain why there is a greater prevalence of nocturia with age.  
Although there are reported circadian patterns of ANP and PRA secretion, we 
were unable to detect this in our study (Cugini et al., 1992a; Maggioni, Lucini, Antinozzi, 
& Pagani, 2001; Mulrow & Ganong, 1961; Portaluppi et al., 1990; Rittig et al., 1991).The 
lack of circadian rhythm of ANP in older subjects of our study agrees with the reports of 
ANP circadian rhythm lost in the elderly (Cugini et al., 1992). The older subjects in 
Cugini‟s group still showed rhythms in aldosterone and renin secretion, suggesting that 
the inhibitory action might be lost. The inhibitory effect that ANP has on the renin-
angiotensin-aldosterone system may contribute to the higher prevalence of nocturia with 
age. Both studies used constant routines to control for exogenous influences but there 
were still differences in the results. However, we also did not detect a rhythm in ANP in 
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the young subjects in our study, suggesting either a problem with the ANP sample 
collection or assay procedures, or a lack of rhythmicity in ANP under well-controlled 
constant conditions.  
ANP is released in response to high blood pressure in order to reduce the 
hemodynamic pressure of water and sodium on the system. A strictly controlled diet is 
necessary to monitor the effects of any change in blood pressure caused by food and fluid 
intake. One study showed that subjects with no sodium restriction had clearance rates of 
ANP that were closely related to their sodium intake (Iervasi et al., 1993). Similarly, 
plasma ANP levels were higher in high salt intake groups relative to low salt intake 
groups (Houben et al., 1998). Sodium levels affect ANP activity, and ANP is an inhibitor 
of aldosterone and renin secretion. Therefore, the diet also affects the plasma aldosterone 
and renin concentration. It was observed that ANP is a stronger inhibitor of aldosterone 
(Dessì-Fulgheri et al., 1999).  Nevertheless, the inhibitory actions of ANP may suggest 
that there is an amplified physiological effect of diuresis, and in turn, nocturia. The 
controlled diet and nutrition for our subjects may need to be adjusted in order to prevent 
masking any circadian rhythm for ANP. A detailed investigation of the hemodynamic 
changes would ANP would also help future studies. If we found evidence of higher ANP 
levels at night in older subjects, this would help explain the greater prevalence of nocturia 
in older subjects.  
The absence of a circadian rhythm of PRA in our subjects may be due to the well 
documented age-related decline in the amount of slow-wave sleep per night (Carskadon 
& Dement, 2011). Less slow-wave sleep would shorten the amount of NREM sleep. Few 
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studies have shown that plasma renin activity follows an ultradian rhythm where the 
levels rise during NREM sleep, and fall during REM sleep (Brandenberger et al., 1994; 
Brandenberger, Follenius, Simon, Ehrhart, & Libert, 1988; Lightman et al., 1981). A 
recent study has shown the same ultradian rhythm of plasma renin activity (Schüssler et 
al., 2010). However, these studies did not utilize the constant routine with adequate 
adjustment days to accurately detect a circadian rhythm.   
During a Constant Routine, subjects are deprived of sleep. Sleep deprivation in 
healthy children resulted in significantly more urine output, lower levels of plasma AVP, 
renin, angiotensin II, and no change in aldosterone, relative to normal sleep (Mahler et 
al., 2012). These changes lead to less sodium and water reabsorption in the kidney, and 
thus more urine output and nocturia. Adult men also appeared to have excess nocturnal 
urine output during sleep deprivation (Kamperis, Hagstroem, Radvanska, Rittig, & 
Djurhuus, 2010). Acute sleep deprivation has significant effects on urine output in both 
the young and old. This should be further investigated in order to better understand data 
from a routine that helps unmask external influences on circadian rhythms. 
Overall, in the questionnaire study, we found that poorer sleep quality was 
associated with more urological complaints in both women and men. In men, daytime 
sleepiness was also correlated with urological complaints, and decreased quality of sleep 
was correlated with increased daytime sleepiness. In the hormone study, we found 
evidence for a sleep-independent increase in aldosterone levels at night, suggestive of an 
underlying rhythm in aldosterone secretion.  
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